期刊
PHARMACEUTICAL STATISTICS
卷 20, 期 2, 页码 256-271出版社
WILEY
DOI: 10.1002/pst.2073
关键词
Bayesian predictive power; clinical trials; sample size
The Bayesian paradigm is ideal for updating uncertainties and making predictions based on data. Bayesian predictive power (BPP) is crucial for assessing the success of a clinical trial. This paper provides mathematical expressions and a design framework to help practitioners utilize BPP in adaptive trial design.
The Bayesian paradigm provides an ideal platform to update uncertainties and carry them over into the future in the presence of data. Bayesian predictive power (BPP) reflects our belief in the eventual success of a clinical trial to meet its goals. In this paper we derive mathematical expressions for the most common types of outcomes, to make the BPP accessible to practitioners, facilitate fast computations in adaptive trial design simulations that use interim futility monitoring, and propose an organized BPP-based phase II-to-phase III design framework.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据